180 related articles for article (PubMed ID: 32088128)
21. Discovery of the First Potent IDO1/IDO2 Dual Inhibitors: A Promising Strategy for Cancer Immunotherapy.
He X; He G; Chu Z; Wu H; Wang J; Ge Y; Shen H; Zhang S; Shan J; Peng K; Wei Z; Zou Y; Xu Y; Zhu Q
J Med Chem; 2021 Dec; 64(24):17950-17968. PubMed ID: 34854662
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and structure-activity relationship study of novel naphthoindolizine and indolizinoquinoline-5,12-dione derivatives as IDO1 inhibitors.
Yang R; Chen Y; Pan L; Yang Y; Zheng Q; Hu Y; Wang Y; Zhang L; Sun Y; Li Z; Meng X
Bioorg Med Chem; 2018 Sep; 26(17):4886-4897. PubMed ID: 30170925
[TBL] [Abstract][Full Text] [Related]
23. Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening.
Guo W; Yao S; Sun P; Yang TB; Tang CP; Zheng MY; Ye Y; Meng LH
Acta Pharmacol Sin; 2020 Mar; 41(3):423-431. PubMed ID: 31197246
[TBL] [Abstract][Full Text] [Related]
24. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
[TBL] [Abstract][Full Text] [Related]
25. A theranostic probe of indoleamine 2,3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy.
Wu Y; Zhang Y; Chen X; Hu Y; Dong G; Guo Y; Sheng C
Eur J Med Chem; 2021 Mar; 213():113163. PubMed ID: 33482599
[TBL] [Abstract][Full Text] [Related]
26. Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.
Weng T; Qiu X; Wang J; Li Z; Bian J
Eur J Med Chem; 2018 Jan; 143():656-669. PubMed ID: 29220788
[TBL] [Abstract][Full Text] [Related]
27. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
Yang L; Chen Y; He J; Njoya EM; Chen J; Liu S; Xie C; Huang W; Wang F; Wang Z; Li Y; Qian S
Bioorg Med Chem; 2019 Mar; 27(6):1087-1098. PubMed ID: 30773421
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors.
Koblish HK; Hansbury MJ; Bowman KJ; Yang G; Neilan CL; Haley PJ; Burn TC; Waeltz P; Sparks RB; Yue EW; Combs AP; Scherle PA; Vaddi K; Fridman JS
Mol Cancer Ther; 2010 Feb; 9(2):489-98. PubMed ID: 20124451
[TBL] [Abstract][Full Text] [Related]
29. The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors.
Fallarini S; Bhela IP; Aprile S; Torre E; Ranza A; Orecchini E; Panfili E; Pallotta MT; Massarotti A; Serafini M; Pirali T
ChemMedChem; 2021 Nov; 16(22):3439-3450. PubMed ID: 34355531
[TBL] [Abstract][Full Text] [Related]
30. Discovery and optimization of substituted oxalamides as novel heme-displacing IDO1 inhibitors.
Steeneck C; Kinzel O; Anderhub S; Hornberger M; Pinto S; Morschhaeuser B; Albers M; Sonnek C; Czekańska M; Hoffmann T
Bioorg Med Chem Lett; 2021 Feb; 33():127744. PubMed ID: 33333163
[TBL] [Abstract][Full Text] [Related]
31. Discovery of potent IDO1 inhibitors derived from tryptophan using scaffold-hopping and structure-based design approaches.
Zou Y; Wang Y; Wang F; Luo M; Li Y; Liu W; Huang Z; Zhang Y; Guo W; Xu Q; Lai Y
Eur J Med Chem; 2017 Sep; 138():199-211. PubMed ID: 28667875
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel naphthoquinone derivatives as IDO1 inhibitors.
Pan L; Zheng Q; Chen Y; Yang R; Yang Y; Li Z; Meng X
Eur J Med Chem; 2018 Sep; 157():423-436. PubMed ID: 30103191
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory investigation of niacin derivatives on metalloenzyme indoleamine 2,3-dioxygenase 1 for its immunomodulatory function.
Yan D; Xu J; Tan X
Metallomics; 2021 Feb; 13(3):. PubMed ID: 33638642
[TBL] [Abstract][Full Text] [Related]
34. Effective Virtual Screening Strategy toward heme-containing proteins: Identification of novel IDO1 inhibitors.
Zou Y; Hu Y; Ge S; Zheng Y; Li Y; Liu W; Guo W; Zhang Y; Xu Q; Lai Y
Eur J Med Chem; 2019 Dec; 184():111750. PubMed ID: 31610376
[TBL] [Abstract][Full Text] [Related]
35. Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening.
Sari S; Tomek P; Leung E; Reynisson J
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795096
[TBL] [Abstract][Full Text] [Related]
36. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
[TBL] [Abstract][Full Text] [Related]
37. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
[TBL] [Abstract][Full Text] [Related]
38. Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.
Huang R; Jing X; Huang X; Pan Y; Fang Y; Liang G; Liao Z; Wang H; Chen Z; Zhang Y
J Med Chem; 2020 Feb; 63(4):1544-1563. PubMed ID: 31999451
[TBL] [Abstract][Full Text] [Related]
39. A multicomponent approach in the discovery of indoleamine 2,3-dioxygenase 1 inhibitors: Synthesis, biological investigation and docking studies.
Griglio A; Torre E; Serafini M; Bianchi A; Schmid R; Coda Zabetta G; Massarotti A; Sorba G; Pirali T; Fallarini S
Bioorg Med Chem Lett; 2018 Feb; 28(4):651-657. PubMed ID: 29398544
[TBL] [Abstract][Full Text] [Related]
40. A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Zheng Y; Stafford PM; Stover KR; Mohan DC; Gupta M; Keske EC; Schiavini P; Villar L; Wu F; Kreft A; Thomas K; Raaphorst E; Pasangulapati JP; Alla SR; Sharma S; Mittapalli RR; Sagamanova I; Johnson SL; Reed MA; Weaver DF
ChemMedChem; 2021 Jul; 16(14):2195-2205. PubMed ID: 33759400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]